A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute Pyelonephritis

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

July 31, 2024

Conditions

Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)

Interventions

DRUG

HRS -8427

The dose and frequency of administration were adjusted according to the eGFR.

DRUG

Imipenem and Cilastatin Sodium

The dose and frequency of administration were adjusted according to the eGFR .

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY